Upon recommendation by underwriters’ counsel, members of CRA’s accounting and advisory team assisted a US-based bio-technology company in advance of its IPO by advising on existing compliance procedures, tightening financial controls, and enhancing internal reporting, governance, and risk management functions. CRA team members recommended and implemented both qualitative and systems-based solutions designed to address regulatory requirements.
Safe Harbor for M&A-Driven Voluntary Self-Disclosures of Criminal Misconduct
On October 4, 2023, Deputy Attorney General Lisa Monaco announced the Department of Justice’s (DOJ) new Safe Harbor Policy for criminal misconduct discovered...